[go: up one dir, main page]

NO20082394L - Polypeptidmarkor for diagnostikk og vurdering av vaskulaere sykdommer - Google Patents

Polypeptidmarkor for diagnostikk og vurdering av vaskulaere sykdommer

Info

Publication number
NO20082394L
NO20082394L NO20082394A NO20082394A NO20082394L NO 20082394 L NO20082394 L NO 20082394L NO 20082394 A NO20082394 A NO 20082394A NO 20082394 A NO20082394 A NO 20082394A NO 20082394 L NO20082394 L NO 20082394L
Authority
NO
Norway
Prior art keywords
polypeptide marker
assessment
diagnosis
vascular diseases
polypeptide
Prior art date
Application number
NO20082394A
Other languages
English (en)
Inventor
Harald Mischak
Original Assignee
Mosaiques Diagnostics & Therap
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mosaiques Diagnostics & Therap filed Critical Mosaiques Diagnostics & Therap
Publication of NO20082394L publication Critical patent/NO20082394L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Det beskrives en fremgangsmåte for diagnostisering av vaskulære sykdommer (VD), som omfatter det trinn å bestemme nærværet eller fraværet av minst én polypeptidmarkør i en prøve, hvor nevnte polypeptidmarkør er valgt blant markører 1 til 526, som kjennetegnes ved verdier for molekylmassene og migreringstider (CE-tider).
NO20082394A 2005-11-30 2008-05-27 Polypeptidmarkor for diagnostikk og vurdering av vaskulaere sykdommer NO20082394L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005057382 2005-11-30
EP06120879 2006-09-19
PCT/EP2006/069096 WO2007063089A2 (de) 2005-11-30 2006-11-30 Polypeptidmarker zur diagnostik und beurteilung vaskulären erkrankungen

Publications (1)

Publication Number Publication Date
NO20082394L true NO20082394L (no) 2008-08-26

Family

ID=38092603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082394A NO20082394L (no) 2005-11-30 2008-05-27 Polypeptidmarkor for diagnostikk og vurdering av vaskulaere sykdommer

Country Status (12)

Country Link
US (2) US20100126861A1 (no)
EP (1) EP1955075A2 (no)
JP (1) JP5165580B2 (no)
KR (1) KR20080074190A (no)
AU (1) AU2006319138B2 (no)
BR (1) BRPI0619248A2 (no)
CA (1) CA2631602A1 (no)
EA (1) EA014529B1 (no)
IL (1) IL191605A0 (no)
NO (1) NO20082394L (no)
SG (1) SG170009A1 (no)
WO (1) WO2007063089A2 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2478377A2 (de) * 2009-09-14 2012-07-25 Mosaiques Diagnostics And Therapeutics AG Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0206903B8 (pt) * 2002-12-20 2021-07-27 Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp método de prognóstico de uma predisposição para o desenvolvimento de hipertensão e lesões no coração, sistema nervoso, sistema vascular ou rins, e uso da isoforma de 90 kda da enzima conversora de angiotensina i no referido método
WO2004089184A2 (en) * 2003-04-01 2004-10-21 Diadexus, Inc. NEW USES OF Lp-PLA2 IN COMBINATION TO ASSESS CORONARY RISK
CA2539430C (en) * 2003-09-23 2015-03-17 The General Hospital Corporation Screening for gestational disorders with sex hormone binding globulin as biomarker

Also Published As

Publication number Publication date
SG170009A1 (en) 2011-04-29
US20150247865A1 (en) 2015-09-03
WO2007063089A3 (de) 2008-01-17
KR20080074190A (ko) 2008-08-12
EP1955075A2 (de) 2008-08-13
JP2009521670A (ja) 2009-06-04
CA2631602A1 (en) 2007-06-07
IL191605A0 (en) 2008-12-29
EA014529B1 (ru) 2010-12-30
US20100126861A1 (en) 2010-05-27
WO2007063089A2 (de) 2007-06-07
EA200801475A1 (ru) 2009-02-27
JP5165580B2 (ja) 2013-03-21
AU2006319138A1 (en) 2007-06-07
AU2006319138B2 (en) 2013-05-16
BRPI0619248A2 (pt) 2011-09-20

Similar Documents

Publication Publication Date Title
WO2007117444A3 (en) Protein detection by aptamers
NO20080371L (no) Fremgangsmate for a forutsi responsen overfor en behandling
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
EP1439393A3 (en) Detection methods using TIMP 1 for colon cancer diagnosis
EP2315034A3 (en) Means and methods for assessing the risk of cardiac interventions based on GDF-15
WO2009067546A3 (en) Lung cancer markers and uses thereof
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
DK1316801T3 (da) Sammensætninger og fremgangsmåder til detektion og behandling af sygdomme og tilstande, som er relateret til kemokinreceptorer
EP2293075A3 (en) Method for diagnosing neuro-degenerative disease
BR0317394A (pt) Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal
ATE498022T1 (de) Universelle vervielfältigung von fragmentierter rns
WO2006113245A3 (en) Methods for measuring glycan levels of proteins
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
WO2003087761A3 (en) Molecular profiling of disease and therapeutic response using phospho-specific antibodies
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
EP1566448A3 (de) Differenzialdiagnostik mit Hepcidin
WO2011029954A3 (de) Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen
NO20082394L (no) Polypeptidmarkor for diagnostikk og vurdering av vaskulaere sykdommer
DE60041582D1 (de) Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
FR2900936B1 (fr) Procede et methodes de detection de la maladie d'alzheimer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application